Guidelines and Consensus Statements

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancer
Mary L Disis, Sarah F Adams, Jyoti Bajpai, Marcus O Butler, Tyler Curiel, Shelley A Dodt, Laura Doherty, Leisha A Emens, Claire F Friedman, Margaret Gatti-Mays, Melissa A Geller, Amir Jazaeri, Veena S John, Katherine C Kurnit, John B Liao, Haider Mahdi, Anne Mills, Emese Zsiros, Kunle Odunsi

Journal for ImmunoTherapy of Cancer Jun 2023, 11 (6) e006624; DOI: 10.1136/jitc-2022-006624
Leveraging immune resistance archetypes in solid cancer to inform next-generation anticancer therapies
Kristin G Anderson, David A Braun, Aitziber Buqué, Sarah B Gitto, Jennifer L Guerriero, Brendan Horton, Bridget P Keenan, Teresa S Kim, Abigail Overacre-Delgoffe, Marco Ruella, Todd A Triplett, Omkara Veeranki, Vivek Verma, Fan Zhang

Journal for ImmunoTherapy of Cancer Jun 2023, 11 (6) e006533; DOI: 10.1136/jitc-2022-006533
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gastrointestinal cancer
Ronan J Kelly, Katherine Bever, Joseph Chao, Kristen K Ciombor, Cathy Eng, Marwan Fakih, Lipika Goyal, Joleen Hubbard, Renuka Iyer, Holly T Kemberling, Smitha Krishnamurthi, Geoffrey Ku, Mindy Mintz Mordecai, Van K Morris, Andrew Scott Paulson, Valerie Peterson, Manish A Shah, Dung T Le

Journal for ImmunoTherapy of Cancer Jun 2023, 11 (6) e006658; DOI: 10.1136/jitc-2022-006658
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of hepatocellular carcinoma
Tim F Greten, Ghassan K Abou-Alfa, Ann-Lii Cheng, Austin G Duffy, Anthony B. El-Khoueiry, Richard S Finn, Peter R Galle, Lipika Goyal, Aiwu Ruth He, Ahmed O Kaseb, Robin Kate Kelley, Riccardo Lencioni, Amaia Lujambio, Donna Mabry Hrones, David J Pinato, Bruno Sangro, Roberto I Troisi, Andrea Wilson Woods, Thomas Yau, Andrew X Zhu, Ignacio Melero

Journal for ImmunoTherapy of Cancer Sep 2021, 9 (9) e002794; DOI: 10.1136/jitc-2021-002794
Recommendations for standardizing biopsy acquisition and histological assessment of immune checkpoint inhibitor-associated colitis
Christopher Ma, Rish K Pai, David F Schaeffer, Jonathan Krell, Leonardo Guizzetti, Stefanie C McFarlane, John K MacDonald, Won-Tak Choi, Roger M Feakins, Richard Kirsch, Gregory Y Lauwers, Reetesh K Pai, Christophe Rosty, Amitabh Srivastava, Joanna C. Walsh, Brian G Feagan, Vipul Jairath

Journal for ImmunoTherapy of Cancer Mar 2022, 10 (3) e004560; DOI: 10.1136/jitc-2022-004560
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of nonmelanoma skin cancer
Ann W Silk, Christopher A Barker, Shailender Bhatia, Kathryn B Bollin, Sunandana Chandra, Zeynep Eroglu, Brian R Gastman, Kari L Kendra, Harriet Kluger, Evan J Lipson, Kathleen Madden, David M Miller, Paul Nghiem, Anna C Pavlick, Igor Puzanov, Guilherme Rabinowits, Emily S Ruiz, Vernon K Sondak, Edward A Tavss, Michael T Tetzlaff, Isaac Brownell

Journal for ImmunoTherapy of Cancer Jul 2022, 10 (7) e004434; DOI: 10.1136/jitc-2021-004434
Society for Immunotherapy of Cancer (SITC) consensus definitions for resistance to combinations of immune checkpoint inhibitors with targeted therapies
Michael B Atkins, Paolo A Ascierto, David Feltquate, James L Gulley, Douglas B Johnson, Nikhil I Khushalani, Jeffrey Sosman, Timonthy A Yap, Harriet Kluger, Ryan J Sullivan, Hussein Tawbi

Journal for ImmunoTherapy of Cancer Mar 2023, 11 (3) e005923; DOI: 10.1136/jitc-2022-005923
Society for Immunotherapy of Cancer (SITC) consensus definitions for resistance to combinations of immune checkpoint inhibitors
Harriet Kluger, J Carl Barrett, Justin F Gainor, Omid Hamid, Michael Hurwitz, Theresa LaVallee, Rebecca A Moss, Roberta Zappasodi, Ryan J Sullivan, Hussein Tawbi, Elad Sharon

Journal for ImmunoTherapy of Cancer Mar 2023, 11 (3) e005921; DOI: 10.1136/jitc-2022-005921
Society for Immunotherapy of Cancer (SITC) consensus definitions for resistance to combinations of immune checkpoint inhibitors with chemotherapy
Naiyer Rizvi, Foluso O Ademuyiwa, Z Alexander Cao, Helen X Chen, Robert L Ferris, Sarah B Goldberg, Matthew D Hellmann, Ranee Mehra, Ina Rhee, Jong Chul Park, Harriet Kluger, Hussein Tawbi, Ryan J Sullivan

Journal for ImmunoTherapy of Cancer Mar 2023, 11 (3) e005920; DOI: 10.1136/jitc-2022-005920
Society for Immunotherapy of Cancer (SITC) consensus definitions for immune checkpoint inhibitor-associated immune-related adverse events (irAEs) terminology
Jarushka Naidoo, Catherine Murphy, Michael B Atkins, Julie R Brahmer, Stephane Champiat, David Feltquate, Lee M Krug, Javid Moslehi, M Catherine Pietanza, Joanne Riemer, Caroline Robert, Elad Sharon, Maria E Suarez-Almazor, Karthik Suresh, Michelle Turner, Jeffrey Weber, Laura C Cappelli

Journal for ImmunoTherapy of Cancer Mar 2023, 11 (3) e006398; DOI: 10.1136/jitc-2022-006398

Main menu

Guidelines and Consensus Statements

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Guidelines and Consensus Statements

Pages